Trial intelligence / Profile preview

Efficacy and tolerability of nimesulide for the treatment of migraine attacks

2005-000583-28Phase 4Completed

Sponsor
Helsinn
Start
Sep 2005
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised, double-blind trial in migraine comparing Aulin (nimesulide) sequence with Placebo sequence (2 arms). Primary endpoint: Pain relief at 2 hours. Started Sep 2005; status: completed.

02

Drugs

nimesulide
03

Conditions

migraine

Beyond the preview

Go deeper on 2005-000583-28.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2005-000583-28.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call